Monoclonal antibodies to Cache Valley virus for serological diagnosis
Cache Valley virus (CVV) is a mosquito-borne virus in the genus Orthobunyavirus , family Peribunyaviridae . It was first isolated from a Culiseta inorata mosquito in Cache Valley, Utah in 1956 and is known to circulate widely in the Americas. While only a handful of human cases have been reported si...
Uložené v:
| Vydané v: | PLoS neglected tropical diseases Ročník 16; číslo 1; s. e0010156 |
|---|---|
| Hlavní autori: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
Public Library of Science
01.01.2022
Public Library of Science (PLoS) |
| Predmet: | |
| ISSN: | 1935-2735, 1935-2727, 1935-2735 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | Cache Valley virus (CVV) is a mosquito-borne virus in the genus
Orthobunyavirus
, family
Peribunyaviridae
. It was first isolated from a
Culiseta inorata
mosquito in Cache Valley, Utah in 1956 and is known to circulate widely in the Americas. While only a handful of human cases have been reported since its discovery, it is the causative agent of fetal death and severe malformations in livestock. CVV has recently emerged as a potential viral pathogen causing severe disease in humans. Currently, the only serological assay available for diagnostic testing is plaque reduction neutralization test which takes several days to perform and requires biocontainment. To expand diagnostic capacity to detect CVV infections by immunoassays, 12 hybridoma clones secreting anti-CVV murine monoclonal antibodies (MAbs) were developed. All MAbs developed were found to be non-neutralizing and specific to the nucleoprotein of CVV. Cross-reactivity experiments with related orthobunyaviruses revealed several of the MAbs reacted with Tensaw, Fort Sherman, Tlacotalpan, Maguari, Playas, and Potosi viruses. Our data shows that MAbs CVV14, CVV15, CVV17, and CVV18 have high specific reactivity as a detector in an IgM antibody capture test with human sera. |
|---|---|
| Bibliografia: | new_version ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 The authors have declared that no competing interests exist. |
| ISSN: | 1935-2735 1935-2727 1935-2735 |
| DOI: | 10.1371/journal.pntd.0010156 |